Sign Up to like & get
recommendations!
1
Published in 2021 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-021-03021-3
Abstract: Exosomal PD-L1 (exoPD-L1) could induce immunosuppression functionally, thus impairing patients’ survival in melanoma, NSCLC, and gastric cancer. However, no evidence demonstrates the feasibility of circulating exoPD-L1 and soluble PD-L1 (sPD-L1) as biomarkers for prognosis and…
read more here.
Keywords:
cell infiltration;
exopd spd;
spd;